Last reviewed · How we verify

NCT06060119

Comparison of Microneedling and CTG for Gingival Augmentation- A RCT

Status unknown Phase 2 Last updated 29 September 2023
What this trial tests

Phase 2 trial testing microneedling in Gingival Phenotype in 12 participants. Status unknown.

Timeline
28 November 2023
Primary endpoint
30 June 2024
30 July 2024

Quick facts

Lead sponsorKrishnadevaraya College of Dental Sciences & Hospital
PhasePhase 2
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment12
Start date28 November 2023
Primary completion30 June 2024
Estimated completion30 July 2024

Drugs / interventions tested

Conditions studied

Sponsor

Krishnadevaraya College of Dental Sciences & Hospital

Who can join

Adults 18 to 60, any sex, with Gingival Phenotype. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The presence study is toComparison of Microneedling with Subepithelial Connective Tissue Auto Graft for Gingival Augmentation- A Randomized Case Control Trial. The trial is in accordance with the Consolidated Standards of Reporting Trials (CONSORT) criteria, 2010.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of microneedling

Trials testing the same drug.

Other Krishnadevaraya College of Dental Sciences & Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06060119.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing